Correlation Between Firan Technology and Cipher Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Firan Technology and Cipher Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Firan Technology and Cipher Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Firan Technology Group and Cipher Pharmaceuticals, you can compare the effects of market volatilities on Firan Technology and Cipher Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Firan Technology with a short position of Cipher Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Firan Technology and Cipher Pharmaceuticals.

Diversification Opportunities for Firan Technology and Cipher Pharmaceuticals

0.15
  Correlation Coefficient

Average diversification

The 3 months correlation between Firan and Cipher is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Firan Technology Group and Cipher Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cipher Pharmaceuticals and Firan Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Firan Technology Group are associated (or correlated) with Cipher Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cipher Pharmaceuticals has no effect on the direction of Firan Technology i.e., Firan Technology and Cipher Pharmaceuticals go up and down completely randomly.

Pair Corralation between Firan Technology and Cipher Pharmaceuticals

Assuming the 90 days trading horizon Firan Technology Group is expected to generate 0.95 times more return on investment than Cipher Pharmaceuticals. However, Firan Technology Group is 1.05 times less risky than Cipher Pharmaceuticals. It trades about 0.18 of its potential returns per unit of risk. Cipher Pharmaceuticals is currently generating about 0.08 per unit of risk. If you would invest  864.00  in Firan Technology Group on April 20, 2025 and sell it today you would earn a total of  251.00  from holding Firan Technology Group or generate 29.05% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Firan Technology Group  vs.  Cipher Pharmaceuticals

 Performance 
       Timeline  
Firan Technology 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Firan Technology Group are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain technical and fundamental indicators, Firan Technology displayed solid returns over the last few months and may actually be approaching a breakup point.
Cipher Pharmaceuticals 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Cipher Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal technical indicators, Cipher Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Firan Technology and Cipher Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Firan Technology and Cipher Pharmaceuticals

The main advantage of trading using opposite Firan Technology and Cipher Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Firan Technology position performs unexpectedly, Cipher Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cipher Pharmaceuticals will offset losses from the drop in Cipher Pharmaceuticals' long position.
The idea behind Firan Technology Group and Cipher Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk